5 Results for "

Immune exclusion

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Immune exclusion" in MCE Product Catalog:

Cat. No.: HY-175660
Target:  

Heme Oxygenase (HO)

Research Areas:  

Cancer

KCL-HO-1i is an orally active heme oxygenase-1 (HO-1) inhibitor (rat HO-1: IC50 = 123 nM) and human HO-1: IC50 = 128 nM). KCL-HO-1i targets immunosuppressive LYVE-1 + perivascular tumor-associated macrophages (PvTAMs) in the tumor microenvironment (TME), reduces PvTAM-mediated immune exclusion. KCL-HO-1i demonstrates synergistic anti-tumor efficacy with chemotherapy in MMTV-PyMT spontaneous breast cancer mice or C57Bl/6 mice bearing subcutaneous MN-MCA1 sarcomas. KCL-HO-1i can be used for the study of cancer .
loading...
    loading...
Cat. No.: HY-176185
DDR1 ligand 1 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). DDR1 ligand 1 can be used for the synthesis of PROTAC DDR1 degrader-1 (HY-176184) .
loading...
    loading...
Cat. No.: HY-176187
CAS No.: 3081612-71-4
Research Areas:  

Cancer

DDR1 ligand 1-piperidine is a target protein ligand and linker conjugate, which can be used for the synthesis of PROTAC DDR1 degrader-1 (HY-176184) .
loading...
    loading...
Cat. No.: HY-176186
CAS No.: 1056123-56-8
Target:  

PROTAC Linkers

Research Areas:  

Cancer

4-Hydroxy-1-piperidinepropanamide is a PROTAC linker that can be used in the synthesis of PROTAC DDR1 degrader-1 (HY-176184) .
loading...
    loading...
Cat. No.: HY-176188
CAS No.: 3081612-41-8
Research Areas:  

Cancer

Lenalidomide-5-Br-amide-C2-Br is an E3 ligase ligand-linker conjugate. Lenalidomide-5-Br-amide-C2-Br can be used to synthesize PROTAC DDR1 degrader-1 (HY-176184) .
loading...
    loading...